Scientists have developed an innovative nanocarrier that can selectively target and deliver a chemotherapy payload to cancer cells without adverse effects on healthy cells.
University of Salford researchers have uncovered ways that energetic cancer stem cells (e-CSCs) are responsible for cell growth, and consequently have identified new therapeutic targets.....
Scottish biotech TC BioPharm (TCB) has won European Union funding to develop a new “off-the-shelf” cell therapy for several types of solid tumour cancers.
Aids R&D initiatives to advance precision medicine. AMSBIO has introduced a new range of cancer cell line models and culture media for the most difficult to culture tumour types where no models may exist.